Aeterna Zentaris to Announce Third Quarter 2013 Financial and Operating Results on November 5, 2013

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\nQUEBEC CITY, Oct. 29, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") will announce its third quarter 2013\n financial and operating results after market close on Tuesday, November\n 5, 2013. The Company will host a conference call to discuss these\n results on Wednesday, November 6, 2013, at 8:30 a.m., Eastern Time.\n\n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers:\n in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.\n A replay of the webcast will also be available on the Company's website\n for a period of 30 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in\n developing novel treatments in oncology and endocrinology. The\n Company's pipeline encompasses compounds from drug discovery to\n regulatory approval. For more information, visit www.aezsinc.com.\n\n\nSOURCE Aeterna Zentaris Inc.\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] Copyright CNW Group 2013","length":2125,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.